Vistin Pharma ASA VISTN

OSL: VISTN | ISIN: NO0010734122   10/04/2026
22,30 NOK (+1,36%)
(+1,36%)   10/04/2026

20 februari 2026 · Vistin Pharma ASA: Mandatory notification of trade · Persbericht

12 februari 2026 · Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend · Persbericht

12 februari 2026 · Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results · Persbericht

5 februari 2026 · Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call · Persbericht

31 oktober 2025 · Vistin Pharma ASA: Third quarter and YTD 2025 financial results · Persbericht

24 oktober 2025 · Vistin Pharma ASA: Invitation to Q3 2025 conference call · Persbericht

15 augustus 2025 · Vistin Pharma ASA: Second quarter and YTD 2025 financial results · Persbericht

8 augustus 2025 · Vistin Pharma ASA: Invitation to Q2 2025 conference call · Persbericht

4 juni 2025 · Ex dividend NOK 1.25 today · Persbericht

22 mei 2025 · Vistin Pharma ASA: Minutes from the annual general meeting 2025 · Persbericht

22 mei 2025 · Disclosure of voting rights at AGM in Vistin Pharma ASA · Persbericht

7 mei 2025 · Vistin Pharma ASA (VISTN): Update from the Election Committee · Persbericht

6 mei 2025 · Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding · Persbericht

29 april 2025 · Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025 · Persbericht

25 april 2025 · 2024 Annual Report Vistin Pharma ASA · Persbericht

25 april 2025 · Vistin Pharma ASA: First quarter 2025 financial results · Persbericht

15 april 2025 · Vistin Pharma ASA: Invitation to Q1 2025 conference call · Persbericht

13 februari 2025 · Vistin Pharma ASA: Key information relating to the proposed cash dividend · Persbericht

13 februari 2025 · Vistin Pharma ASA: Fourth quarter and preliminary 2024 financial results · Persbericht

6 februari 2025 · Vistin Pharma ASA: Invitation to Q4 2024 conference call · Persbericht

Mijn selecties